These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 34373830)
1. Telogen Effluvium after SARS-CoV-2 Infection: A Series of Cases and Possible Pathogenetic Mechanisms. Rossi A; Magri F; Sernicola A; Michelini S; Caro G; Muscianese M; Di Fraia M; Chello C; Fortuna MC; Grieco T Skin Appendage Disord; 2021 Jul; 21(5):1-5. PubMed ID: 34373830 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of patients with telogen effluvium during the pandemic: May the monocytes be responsible for post COVID-19 telogen effluvium? Koç Yıldırım S; Erbağcı E; Demirel Öğüt N J Cosmet Dermatol; 2022 May; 21(5):1809-1815. PubMed ID: 35201647 [TBL] [Abstract][Full Text] [Related]
3. A systematic review of acute telogen effluvium, a harrowing post-COVID-19 manifestation. Hussain N; Agarwala P; Iqbal K; Omar HMS; Jangid G; Patel V; Rathore SS; Kumari C; Velasquez-Botero F; López GAB; Vishwakarma Y; Nipu AP; Ahmed NK J Med Virol; 2022 Apr; 94(4):1391-1401. PubMed ID: 34931698 [TBL] [Abstract][Full Text] [Related]
5. Telogen effluvium related to post severe Sars-Cov-2 infection: Clinical aspects and our management experience. Rizzetto G; Diotallevi F; Campanati A; Radi G; Bianchelli T; Molinelli E; Mazzanti S; Offidani A Dermatol Ther; 2021 Jan; 34(1):e14547. PubMed ID: 33190397 [TBL] [Abstract][Full Text] [Related]
6. The role of autologous micrografts injection from the scalp tissue in the treatment of COVID-19 associated telogen effluvium: Clinical and trichoscopic evaluation. Hawwam SA; Ismail M; Elhawary EE Dermatol Ther; 2022 Jul; 35(7):e15545. PubMed ID: 35486375 [TBL] [Abstract][Full Text] [Related]
7. Red LED light therapy for telogen effluvium in the course of long COVID in patients with and without androgenetic alopecia. Gerkowicz A; Bartosińska J; Krakowski P; Karpiński R; Krasowska D; Raczkiewicz D; Kwasny M; Krasowska D Ann Agric Environ Med; 2024 Jun; 31(2):239-247. PubMed ID: 38940108 [TBL] [Abstract][Full Text] [Related]
8. COVID-19 infection is a major cause of acute telogen effluvium. Sharquie KE; Jabbar RI Ir J Med Sci; 2022 Aug; 191(4):1677-1681. PubMed ID: 34467470 [TBL] [Abstract][Full Text] [Related]
9. Trichodynia and telogen effluvium in COVID-19 patients: Results of an international expert opinion survey on diagnosis and management. Starace M; Iorizzo M; Sechi A; Alessandrini AM; Carpanese M; Bruni F; Vara G; Apalla Z; Asz-Sigall D; Barruscotti S; Camacho F; Doche I; Estrada BD; Dhurat R; Gavazzoni MF; Grimalt R; Harries M; Ioannidis D; McMichael A; Melo DF; Oliveira R; Ovcharenko Y; Pirmez R; Ramot Y; Rudnicka L; Shapiro J; Silyuk T; Sinclair R; Tosti A; Vano-Galvan S; Piraccini BM JAAD Int; 2021 Dec; 5():11-18. PubMed ID: 34368790 [TBL] [Abstract][Full Text] [Related]
10. Telogen effluvium and COVID-19: a cross-sectional study. Aldahish A; Vasudevan R; Salem H; Alqahtani A; AlQasim S; Alqhatani A; Al Shahrani M; Al Mohsen L; Hajla M; Calina D; Sharifi-Rad J Eur Rev Med Pharmacol Sci; 2023 Aug; 27(16):7823-7830. PubMed ID: 37667959 [TBL] [Abstract][Full Text] [Related]
11. Management of hair loss after severe acute respiratory syndrome coronavirus 2 infection: Insight into the pathophysiology with implication for better management. Ohyama M; Matsudo K; Fujita T J Dermatol; 2022 Oct; 49(10):939-947. PubMed ID: 35633047 [TBL] [Abstract][Full Text] [Related]
14. COVID-19-induced hair shedding and related risk factors: A Saudi perspective. Bukhari AE; AlDosari DA; AlDosari MA; Muqrin RF; Moazin OM; Almutlq MM; Altalhab SM; Alharithy RS; Alkhalifah AI J Family Med Prim Care; 2023 Dec; 12(12):3304-3311. PubMed ID: 38361868 [TBL] [Abstract][Full Text] [Related]